Center for Drug Evaluation and Research

Which FDA Division Has the Most Stability As AI Tools Get Adopted Across the Agency?

At SXSW, two FDA observers said stability is returning to the agency after painful DOGE personnel cuts last year, though it's not equal across divisions. And now, AI tools are being adopted across the board to improve efficiency.

By Arundhati Parmar

Now, when a patient speaks, pharma and the FDA actually listen

By James E. Valentine* - Whether you call it “patient advocacy,” “patient engagement,” or maybe something a little fancier, in recent years incorporating the patient perspective has become a hot topic issue for FDA and drug developers alike. As FDA...

By FDABlog HPM

The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]

MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.

By Clever Care Health Plan and MedCity News